Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      BRC Therapeutics Appoints Ron Eastman to Board of Directors
      Biotech

      BRC Therapeutics Appoints Ron Eastman to Board of Directors

      June 13, 2026
      Beyond the Double Helix: Phinomics Joins “All Access hosted by Andy Garcia” to Explore Hidden Frontiers in Genetics
      Biotech

      Beyond the Double Helix: Phinomics Joins “All Access hosted by Andy Garcia” to Explore Hidden Frontiers in Genetics

      June 12, 2026
      Roche’s VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies
      Biotech

      Roche’s VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies

      June 11, 2026
      Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders
      Biotech

      Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders

      June 10, 2026
      IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants
      Biotech

      IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

      June 9, 2026
      Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT® in Aggressive Brain Cancer (Glioblastoma)
      Biotech

      Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT® in Aggressive Brain Cancer (Glioblastoma)

      June 8, 2026
      Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association’s 2026 Scientific Sessions
      Biotech

      Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association’s 2026 Scientific Sessions

      June 7, 2026
      SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver
      Biotech

      SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

      June 6, 2026
      Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection
      Biotech

      Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection

      June 5, 2026
      Veeva Summit Previews Falcon and the Path to Agentic Biopharma
      Biotech

      Veeva Summit Previews Falcon and the Path to Agentic Biopharma

      June 4, 2026
      1 2 3 … 144 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026